From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA

🎥 @WainbergZev of @UCLA talks on daNIS-2: NIS793 with nab-paclitaxel and gemcitabine in mPDAC

Watch: 👉http://ow.ly/966T50MIV6t👈

@ASCO #GI23 #GastrointestinalCancer #PancSM #PancreaticCancer

🎥 Ken Kato of National Cancer Center Hospital talks on the 29-month follow-up from CheckMate 648: nivolumab combination therapy in ESCC

Watch: 👉http://ow.ly/3GZs50MIV3Q👈

@ASCO #GI23 #GastrointestinalCancer #ESOCSM

EGFR exon 20 insertion mutations in #LungCancer - find our how to identify these mutations and manage patients in the UK

2nd March at 6-7pm GMT

ft. @DrSanjayPopat @Anna_Minchom @DrRiyazShah @AlastairGreyst2

Organized by @VJOncology & @BTOGORG

Registration now open!

Want something interesting to read this week?

Why not take a look at some of the feature articles we have over on VJOncology?

We've got the latest updates from across a whole range of disease areas, to keep you informed!

Read here: 📖 https://www.vjoncology.com/features/ 📖

🎥 Heinz Josef Lenz (@HJLenz59) of @USC talks on addressing resistance to ICIs in colorectal cancer

Watch: 👉http://ow.ly/12oo50MIP1g👈

@ASCO #GI23 #GastrointestinalCancer #CRCSM #ColorectalCancer

Load More

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA
From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

🎥 @WainbergZev of @UCLA talks on daNIS-2: NIS793 with nab-paclitaxel and gemcitabine in mPDAC

Watch: 👉http://ow.ly/966T50MIV6t👈

@ASCO #GI23 #GastrointestinalCancer #PancSM #PancreaticCancer

🎥 Ken Kato of National Cancer Center Hospital talks on the 29-month follow-up from CheckMate 648: nivolumab combination therapy in ESCC

Watch: 👉http://ow.ly/3GZs50MIV3Q👈

@ASCO #GI23 #GastrointestinalCancer #ESOCSM

EGFR exon 20 insertion mutations in #LungCancer - find our how to identify these mutations and manage patients in the UK

2nd March at 6-7pm GMT

ft. @DrSanjayPopat @Anna_Minchom @DrRiyazShah @AlastairGreyst2

Organized by @VJOncology & @BTOGORG

Registration now open!

Want something interesting to read this week?

Why not take a look at some of the feature articles we have over on VJOncology?

We've got the latest updates from across a whole range of disease areas, to keep you informed!

Read here: 📖 https://www.vjoncology.com/features/ 📖

🎥 Heinz Josef Lenz (@HJLenz59) of @USC talks on addressing resistance to ICIs in colorectal cancer

Watch: 👉http://ow.ly/12oo50MIP1g👈

@ASCO #GI23 #GastrointestinalCancer #CRCSM #ColorectalCancer

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter